We’re proud to be part of ASPIRE2025 in Singapore, where global experts come together to explore the latest advances in reproductive medicine.
It’s inspiring to see worldwide interest in CatSper’s role in fertilization and the need to inform patients about CatSper-related infertility. Together, we are making routine identification of this disease possible — paving the way for personalized fertility care.
We are proud to share that our Co-Founder and Scientific Lead, Samuel Young, was honored with the “Outstanding Oral Presentation Award” at the ASPIRE 2025 conference in Singapore!
His presentation highlighted our story from bench to bedside – how we translate a scientific idea into patient care. Together with medical professionals, we aim to inform patients about CatSper-related Infertility and enable them to have to opportunity to check for this disease.
Thank you to the ASPIRE team for an outstanding event, and to our partner Eshcol Pharmaceutical Group for the warm hospitality!
